Investigation for the preventive effect of Camostat Mesilate contained oral wash on SARS-CoV-2

ishizaki Yasuriro0 个研究点目标入组 400 人开始时间: 2020年9月10日最近更新: 2024年1月22日

适应症

试验速览

暂无简介。

•1.Gender: Any
•2.Age: 20 and over, under 75
•3. Independent living possible person
•4.Persons who can reliably answer questions, measure body temperature, and observe health
•5.Persons who understand this research and complete the consent form
•6.Persons who have been confirmed negative by PCR test

•1.Persons who do not meet the selection criteria
•2.Persons who have been infected with SARS-CoV-2 within 3 months
•3.Persons who have had close contact with SARS-CoV-2 infected persons within 2 weeks
•4.Persons who are taking Camostat Mesilate tablets due to chronic pancreatitis, etc.
•5.Persons who are at risk of developing allergies related to this study
•6.Persons with symptoms such as fever, sore throat, cough, dysgeusia, olfactory sensation, and diarrhea within 3 weeks
•7.Persons who are currently participating in some clinical trial or who participated within 2 months before the start of the trial
•8.Persons who are judged to be unsuitable by the principal investigator and the investigators

发起方

ishizaki Yasuriro